The drug being tested in this study is called Leuprorelin acetate (Leuplin PRO for Injection Kit 22.5 mg). Leuprorelin acetate is being tested to treat people who have prostate cancer.~This study will look at the safety in patients with prostate cancer receiving the drug in the routine clinical setting.~The study will enroll approximately 300 patients.~• Leuprorelin acetate~This multi-center trial will be conducted in Japan.
The purpose of this study is to evaluate the safety in patients with prostate cancer receiving the drug in the routine clinical setting.